AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $287,610 | -8.8% | 6,670 | -38.1% | 0.04% | +2.5% |
| Q1 2024 | $315,207 | +118.8% | 10,780 | +66.6% | 0.04% | +42.9% |
| Q4 2023 | $144,065 | +307.3% | 6,469 | +352.7% | 0.03% | +180.0% |
| Q3 2023 | $35,368 | +71.3% | 1,429 | +96.0% | 0.01% | +66.7% |
| Q2 2023 | $20,645 | +20.0% | 729 | -2.7% | 0.01% | 0.0% |
| Q1 2023 | $17,205 | +9.8% | 749 | +34.2% | 0.01% | 0.0% |
| Q4 2022 | $15,669 | +4.5% | 558 | +8.8% | 0.01% | 0.0% |
| Q3 2022 | $15,000 | – | 513 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 514,711 | $22,194,338 | 5.19% |
| ACUTA CAPITAL PARTNERS, LLC | 78,700 | $3,393,544 | 2.86% |
| Bellevue Group AG | 3,879,548 | $167,286,110 | 2.72% |
| Parkman Healthcare Partners LLC | 446,416 | $19,249,458 | 2.58% |
| Eagle Health Investments LP | 330,830 | $14,265,390 | 2.50% |
| SECTOR GAMMA AS | 121,844 | $5,253,913 | 1.96% |
| Frazier Life Sciences Management, L.P. | 871,974 | $37,599,519 | 1.76% |
| BVF INC/IL | 1,190,107 | $51,317,414 | 1.44% |
| Rock Springs Capital Management LP | 1,044,261 | $45,028,534 | 1.36% |
| FARALLON CAPITAL MANAGEMENT LLC | 5,654,502 | $243,822,126 | 1.15% |